Market revenue in 2023 | USD 77,845.9 million |
Market revenue in 2030 | USD 89,491.5 million |
Growth rate | 2% (CAGR from 2023 to 2030) |
Largest segment | Clinical chemistry |
Fastest growing segment | Medical Microbiology & Cytology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human & Tumor Genetics, Clinical Chemistry, Medical Microbiology & Cytology, Other Esoteric Tests |
Key market players worldwide | Labcorp Holdings Inc, Qiagen NV, Eurofins Scientific SE, Quest Diagnostics Inc, OPKO Health Inc, Siemens Healthineers AG ADR, NeoGenomics Inc, Fresenius Medical Care AG, Sonic Healthcare Ltd, Charles River Laboratories International Inc, SYNLAB Group, Mayo Clinic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical laboratory service market will help companies and investors design strategic landscapes.
Clinical chemistry was the largest segment with a revenue share of 57.65% in 2023. Horizon Databook has segmented the U.S. clinical laboratory service market based on human & tumor genetics, clinical chemistry, medical microbiology & cytology, other esoteric tests covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is the biggest and most developed market for clinical laboratory services. The market in the U.S. is very extensive and accessible to almost the whole population of the country. The high burden of chronic illnesses in the nation require support from clinical laboratory services for efficient patient care and treatment.
For instance, in 2022, the National Association of Chronic Disease Directors stated that nearly 60% of people in the country suffer from a chronic disease. The U.S. government is working to reduce the spread of the virus by improving the number of tests in the country.
The abovementioned factors are creating opportunities in the U.S. market and intensifying the competition. New players are entering the market owing to the lucrative nature of the business in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. clinical laboratory service market , including forecasts for subscribers. This country databook contains high-level insights into U.S. clinical laboratory service market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account